Genpact Files Definitive Proxy Statement for 2025 Annual Meeting
Ticker: G · Form: DEF 14A · Filed: Apr 9, 2025 · CIK: 1398659
| Field | Detail |
|---|---|
| Company | Genpact LTD (G) |
| Form Type | DEF 14A |
| Filed Date | Apr 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, shareholder-voting
Related Tickers: G
TL;DR
Genpact's proxy statement is out for the May 22 meeting. Vote your shares!
AI Summary
Genpact Limited filed a definitive proxy statement (DEF 14A) on April 9, 2025, for its annual meeting on May 22, 2025. The filing concerns the solicitation of proxies from shareholders regarding matters to be voted on at the meeting. Genpact Limited is incorporated in D0 and its fiscal year ends on December 31.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda and proposals for the upcoming annual meeting, allowing them to make informed voting decisions.
Risk Assessment
Risk Level: low — This is a routine annual filing that provides information to shareholders and does not indicate any unusual risks.
Key Numbers
- DEF 14A — Filing Type (Definitive Proxy Statement)
Key Players & Entities
- Genpact Limited (company) — Registrant
- 0001140361-25-013031 (filing_id) — Accession Number
- 20250409 (date) — Filing Date
- 20250522 (date) — Meeting Date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxies from shareholders for an upcoming shareholder meeting.
When was this DEF 14A filed by Genpact Limited?
This DEF 14A filing was filed on April 9, 2025.
What is the scheduled date for Genpact Limited's annual meeting?
The annual meeting for Genpact Limited is scheduled for May 22, 2025.
What is Genpact Limited's fiscal year end?
Genpact Limited's fiscal year ends on December 31.
Where is Genpact Limited incorporated?
Genpact Limited is incorporated in D0.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 9, 2025 regarding Genpact LTD (G).